发明名称 FXIa HAVING ANTITUSSIVE EFFECT
摘要 <p>The activated Factor XI is provided as an antitussive for cough caused by the stimulation at the tracheal bifurcation such as chronic cough. A pharmaceutical composition for prevention, treatment and/or symptom amelioration of cough, comprising a polypeptide chain as an active ingredient and a pharmaceutically acceptable carrier, wherein the polypeptide chain consists of a full length amino acid sequence constituting activated Factor XI (hereinafter also referred to as "FXIa"), the amino acid sequence with one or several amino acids therein being deleted, substituted or added, or a partial sequence of either of the above amino acid sequences, or an amino acid sequence comprising as a part any of the above amino acid sequences.</p>
申请公布号 EP2462942(B1) 申请公布日期 2015.10.21
申请号 EP20100806533 申请日期 2010.08.05
申请人 THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE;NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY;GINKYO ACADEMY KUMAMOTO HEALTH SCIENCE UNIVERSITY 发明人 KAMEI, SHINTARO;SHINDOME, ASAMI;HAMAMOTO, TAKAYOSHI;MAEDA, HIROAKI;HIRASHIMA,MASAKI;OKUDA, SACHIO;UMEHASHI, MISAKO;OGAWA, SACHIE;IMUTA, MEGUMI;AKAIKE, NORIO;TAKAHAMA, KAZUO;WADA, RYOKO
分类号 A61K38/48;A61P11/00;A61P11/14 主分类号 A61K38/48
代理机构 代理人
主权项
地址